Subscribe to these results:

Past Workshops

  1. Update On Marginal Zone Lymphoma (MZL)
  2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
  3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  6. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)
    Part II of Living with Mantle Cell Lymphoma (MCL)
  7. Mantle Cell Lymphoma: Treatment Update
    Part I of Living with Mantle Cell Lymphoma (MCL)
  8. Follicular Lymphoma: Treatment Progress
  9. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
  10. Marginal Zone Lymphoma (MZL): Treatment Updates
  11. What’s New in Diagnostic Technologies for People Living with Blood Cancers
    Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  12. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
  13. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
    Part II of Equity. Every Patient. Every Day. Everywhere.
  14. Transplantation as a Treatment Option for Blood Cancers
  15. Update on Marginal Zone Lymphoma (MZL)
  16. What’s New in Diagnostic Technologies for People Living with Blood Cancers
    Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  17. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  18. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  19. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  20. Update on CAR T-Cell Therapies
  21. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)
    Part II of Living with Mantle Cell Lymphoma
  22. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
  23. Treatment Update on Mantle Cell Lymphoma (MCL)
    Part I of Living with Mantle Cell Lymphoma
  24. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  25. Progress in the Treatment of Follicular Lymphoma
  26. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
  27. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  28. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
  29. What’s New in the Treatment of Hodgkin Lymphoma
  30. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
    Part II of Your Guide to the Latest Cancer Research and Treatment
  31. Treatment Update on Mantle Cell Lymphoma (MCL)
  32. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  33. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  34. Taking Your Blood Cancer Treatment on Schedule
  35. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
  36. Caregiving for Your Loved One with Mantle Cell Lymphoma
  37. Update on Diffuse Large B-Cell Lymphoma
  38. For Caregivers: Coping with a Loved One’s Waldenstrom’s Macroglobulinemia (WM)
  39. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  40. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.